GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Price-to-Owner-Earnings

Medinet Co (TSE:2370) Price-to-Owner-Earnings : (As of Sep. 20, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co Price-to-Owner-Earnings?

As of today (2024-09-20), Medinet Co's share price is 円45.00. Medinet Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Medinet Co's Price-to-Owner-Earnings or its related term are showing as below:


TSE:2370's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 35.405
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-09-20), Medinet Co's share price is 円45.00. Medinet Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-6.01. Therefore, Medinet Co's PE Ratio for today is At Loss.

As of today (2024-09-20), Medinet Co's share price is 円45.00. Medinet Co's EPS without NRI for the trailing twelve months (TTM) ended in was 円-6.05. Therefore, Medinet Co's PE Ratio without NRI for today is At Loss.

During the past 13 years, Medinet Co's highest PE Ratio without NRI was 123.30. The lowest was 0.00. And the median was 110.31.


Medinet Co Price-to-Owner-Earnings Historical Data

The historical data trend for Medinet Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co Price-to-Owner-Earnings Chart

Medinet Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medinet Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medinet Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, Medinet Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medinet Co's Price-to-Owner-Earnings falls into.



Medinet Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medinet Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=45.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medinet Co  (TSE:2370) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Medinet Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Medinet Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co Business Description

Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co Headlines

No Headlines